Ethical Prescribing of Psychotropic Medications for People with Neurodevelopmental Disorders
-
Published:2023-10-12
Issue:
Volume:
Page:
-
ISSN:2366-7532
-
Container-title:Advances in Neurodevelopmental Disorders
-
language:en
-
Short-container-title:Adv Neurodev Disord
Author:
Deb ShoumitroORCID, Limbu Bharati, Bianco Annamaria, Bertelli MarcoORCID
Abstract
Abstract
Objectives
People with neurodevelopmental disorders (NDDs) such as intellectual and developmental disabilities (IDD) and autism are subjected to restrictive practices like physical restraint and the overuse of psychotropic medications for challenging behaviour in the absence of a psychiatric disorder. This practice may lead to human rights violations. Rational and evidence-based shared decision-making for person-centred planning will help reduce this practice.
Methods
We have discussed in this paper the issue of the overmedication of people with NDD, explaining how this practice may violate the United Nations (UN) Convention on the Rights of Persons with Disabilities (CRPD).
Results
We have discussed how the following UN CRPD Articles may be affected by overmedication, including Article 15 (degrading treatment or punishment), 16 (abuse), 17 (the integrity of the person), and 25 (health). The other Articles that may be indirectly affected by this practice are 5 (equality and non-discrimination), 9 (accessibility), 19 (independent living and community inclusion), 21 (access to information), 24 (education), 26 (rehabilitation), 27 (work and employment), 28 (adequate living standard), and 30 (participation in recreation and leisure).
Conclusions
Overmedication of people with NDD, particularly the off-licence use of psychotropics for challenging behaviour, the side effects of these medications impacting the person’s quality of life are likely to violet several UN Articles on Rights of Persons with Disabilities. Following the right guidelines may help reduce these human rights violations.
Publisher
Springer Science and Business Media LLC
Subject
Psychology (miscellaneous),Social Sciences (miscellaneous)
Reference60 articles.
1. Ahmed, Z., Fraser, W., Kerr, M. P., Kiernan, C., Emerson, E., Robertson, J., Felce, D., Allen, D., Baxter, H., & Thomas, J. (2000). Reducing antipsychotic medication in people with a learning disability. British Journal of Psychiatry, 176, 42–46. 2. Barratt, M., Jorgensen, M., Deb, S., Limbu, B., Donley, M., Buchholtz, M., Smith, V., & Wilson, N. (2023). Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework. Journal of Applied Research in Intellectual Disabilities, 36, 486–496. https://doi.org/10.1111/jar.13070 3. Bertelli, M. O., Azeem, M. W., Underwood, L., Scattoni, M. L., Persico, A. M., Ricciardello, A., Sappok, T., Bergmann, T., Keller, R., Bianco, A., Corti, S., Miselli, G., Lassi, S., Croce, L., Bradley, E., & Munir, K. (2022). Autism spectrum disorder. In M. O. Bertelli, S. Deb, K. Munir, A. Hassiotis, & L. Salvador-Carulla (Eds.), Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder (pp. 369–455). Springer Nature. https://doi.org/10.1007/978-3-319-95720-3_16 4. Branford, D. (1996). A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire. Journal of Intellectual Disability Research, 40(4), 358–368. 5. Cervantes, P. E., Matson, J. L., Matheis, M., & Burns, C. O. (2017). Ethical considerations regarding treatment. In J. L. Matson (Ed.), Handbook of Treatments for Autism Spectrum Disorder, Autism and Child Psychopathology Series (pp. 41–58). Springer International Publishing AG. https://doi.org/10.1007/978-3-319-61738-1_3
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|